Things to know about the Phosphodiesterase Enzyme (PDE) Inhibitors

Amol

posted on 2 years ago — updated on 1 second ago

579
views

Phosphodiesterase Enzyme (PDE) Inhibitors Market

Phosphodiesterase enzymes Inhibitors prevents them from degrading cAMP and cGMP molecules in the cell, which is how phosphodiesterase inhibitors work. Nitric oxide, a molecule that controls the production of cAMP and cGMP, works to control physiological processes by lowering calcium concentrations in cells. Ultimately, phosphodiesterase enzymes degrade cAMP and cGMP.

Phosphodiesterase is unable to degrade cAMP and cGMP when it is inhibited. As a result, their concentrations inside the cell rise, which in turn causes calcium concentrations to drop. In the end, this causes smooth muscle relaxation and vasodilation in the target tissues.

https://cmitoc.blogspot.com/2022/11/importance-of-phosphodiesterase-enzyme.html

Amol

Working in Coherent Market Insights. Coherent Market Insights is a global market intelligence and consulting organization, focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan.